Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $373.10 million. The enterprise value is $297.63 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 205.00 million shares outstanding. The number of shares has increased by 115.41% in one year.
| Current Share Class | 205.00M |
| Shares Outstanding | 205.00M |
| Shares Change (YoY) | +115.41% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 13.23% |
| Owned by Institutions (%) | 63.96% |
| Float | 129.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 54.63 |
| Forward PS | 54.46 |
| PB Ratio | 5.21 |
| P/TBV Ratio | 5.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 35.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.42, with a Debt / Equity ratio of 0.89.
| Current Ratio | 5.42 |
| Quick Ratio | 5.30 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -849.23 |
Financial Efficiency
Return on equity (ROE) is -121.94% and return on invested capital (ROIC) is -39.94%.
| Return on Equity (ROE) | -121.94% |
| Return on Assets (ROA) | -32.51% |
| Return on Invested Capital (ROIC) | -39.94% |
| Return on Capital Employed (ROCE) | -64.58% |
| Revenue Per Employee | $114,151 |
| Profits Per Employee | -$1.22M |
| Employee Count | 73 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.42% in the last 52 weeks. The beta is 0.94, so TSHA's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -26.42% |
| 50-Day Moving Average | 1.57 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 64.54 |
| Average Volume (20 Days) | 2,727,948 |
Short Selling Information
The latest short interest is 21.63 million, so 10.55% of the outstanding shares have been sold short.
| Short Interest | 21.63M |
| Short Previous Month | 25.25M |
| Short % of Shares Out | 10.55% |
| Short % of Float | 16.74% |
| Short Ratio (days to cover) | 9.98 |
Income Statement
In the last 12 months, TSHA had revenue of $8.33 million and -$89.30 million in losses. Loss per share was -$0.36.
| Revenue | 8.33M |
| Gross Profit | 8.33M |
| Operating Income | -86.62M |
| Pretax Income | -118.01M |
| Net Income | -89.30M |
| EBITDA | -85.38M |
| EBIT | -86.62M |
| Loss Per Share | -$0.36 |
Full Income StatementBalance Sheet
The company has $139.04 million in cash and $63.56 million in debt, giving a net cash position of $75.48 million or $0.37 per share.
| Cash & Cash Equivalents | 139.04M |
| Total Debt | 63.56M |
| Net Cash | 75.48M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | 71.53M |
| Book Value Per Share | 0.35 |
| Working Capital | 115.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$81.23 million and capital expenditures -$374,000, giving a free cash flow of -$81.60 million.
| Operating Cash Flow | -81.23M |
| Capital Expenditures | -374,000 |
| Free Cash Flow | -81.60M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,039.49% |
| Pretax Margin | -1,071.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -115.41% |
| Shareholder Yield | -115.41% |
| Earnings Yield | -23.93% |
| FCF Yield | -21.87% |
Analyst Forecast
The average price target for TSHA is $6.63, which is 266.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.63 |
| Price Target Difference | 266.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 120.30% |
| EPS Growth Forecast (5Y) | -23.79% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of -3.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.07 |
| Piotroski F-Score | 2 |